metricas
covid
Annals of Hepatology Is hepatitis C direct-acting antiviral therapy a risk factor for the development...
Journal Information

Statistics

Follow this link to access the full text of the article

Concise reviews
Is hepatitis C direct-acting antiviral therapy a risk factor for the development and recurrence of hepatocellular carcinoma? Narrative literature review and clinical practice recommendations
Carolina Delgado Martíneza,
Corresponding author
cdelgadom91@gmail.com

Corresponding author.
, Mariano Gómez-Rubioa,b, Cecilia Gómez-Domíngueza,b
a Division of Digestive Diseases, Hospital Universitario de Getafe, Madrid, Spain
b Universidad Europea de Madrid, Madrid, Spain
Read
4188
Times
was read the article
604
Total PDF
3584
Total HTML
Share statistics
Article information
ISSN: 16652681
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 99 14 113
2025 11 158 12 170
2025 10 275 15 290
2025 9 244 16 260
2025 8 213 22 235
2025 7 147 9 156
2025 6 91 8 99
2025 5 71 6 77
2025 4 63 5 68
2025 3 73 5 78
2025 2 75 4 79
2025 1 62 4 66
2024 12 52 5 57
2024 11 51 5 56
2024 10 35 3 38
2024 9 38 4 42
2024 8 38 10 48
2024 7 28 6 34
2024 6 45 4 49
2024 5 49 4 53
2024 4 45 6 51
2024 3 52 3 55
2024 2 50 8 58
2024 1 48 4 52
2023 12 55 11 66
2023 11 41 6 47
2023 10 49 3 52
2023 9 29 2 31
2023 8 28 12 40
2023 7 20 15 35
2023 6 29 17 46
2023 5 38 17 55
2023 4 41 12 53
2023 3 62 12 74
2023 2 34 17 51
2023 1 32 3 35
2022 12 29 5 34
2022 11 34 3 37
2022 10 30 9 39
2022 9 24 9 33
2022 8 28 11 39
2022 7 28 7 35
2022 6 20 8 28
2022 5 23 3 26
2022 4 16 11 27
2022 3 26 12 38
2022 2 25 7 32
2022 1 35 11 46
2021 12 45 9 54
2021 11 39 11 50
2021 10 40 9 49
2021 9 36 14 50
2021 8 56 10 66
2021 7 24 7 31
2021 6 36 8 44
2021 5 38 13 51
2021 4 199 35 234
2021 3 64 26 90
2021 2 32 15 47
2021 1 31 7 38
2020 12 27 7 34
2020 11 16 4 20
2020 10 10 5 15
2020 9 7 10 17
2020 8 6 9 15
Show all

Follow this link to access the full text of the article

Article options
Tools